Osiris Therapeutics, Inc. (OSIR) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Income from operations: 310K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income from operations: 310K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Osiris Therapeutics, Inc. (NASDAQ: OSIR) reported Q2 EPS of $0.05, $0.07 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $10.4 million versus the consensus estimate of $10.54 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- Movano (MOVE) Misses Q2 EPS by 195c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
